Victory Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.4K Sell
18,619
-95
-0.5% -$68 ﹤0.01% 2465
2025
Q1
$27.5K Sell
18,714
-194,578
-91% -$286K ﹤0.01% 2411
2024
Q4
$945K Sell
213,292
-4,717
-2% -$20.9K ﹤0.01% 1836
2024
Q3
$898K Sell
218,009
-4,564
-2% -$18.8K ﹤0.01% 1822
2024
Q2
$1.45M Buy
222,573
+94,882
+74% +$619K ﹤0.01% 1547
2024
Q1
$1.11M Sell
127,691
-4,096,892
-97% -$35.7M ﹤0.01% 1693
2023
Q4
$48.3M Sell
4,224,583
-182,149
-4% -$2.08M 0.05% 448
2023
Q3
$42.4M Buy
4,406,732
+668,694
+18% +$6.44M 0.05% 460
2023
Q2
$39.8M Buy
3,738,038
+707,706
+23% +$7.53M 0.04% 500
2023
Q1
$31.9M Buy
3,030,332
+127,656
+4% +$1.34M 0.04% 609
2022
Q4
$36M Buy
2,902,676
+845
+0% +$10.5K 0.04% 574
2022
Q3
$30.1M Buy
2,901,831
+2,738,889
+1,681% +$28.4M 0.04% 645
2022
Q2
$1.88M Sell
162,942
-12,046
-7% -$139K ﹤0.01% 1483
2022
Q1
$2.1M Buy
174,988
+17,017
+11% +$204K ﹤0.01% 1484
2021
Q4
$1.84M Buy
157,971
+81,084
+105% +$945K ﹤0.01% 1581
2021
Q3
$1M Buy
76,887
+25,378
+49% +$331K ﹤0.01% 1863
2021
Q2
$663K Buy
51,509
+2,881
+6% +$37.1K ﹤0.01% 2059
2021
Q1
$544K Buy
48,628
+6,625
+16% +$74.1K ﹤0.01% 2165
2020
Q4
$478K Buy
42,003
+9,298
+28% +$106K ﹤0.01% 2104
2020
Q3
$294K Buy
32,705
+12,607
+63% +$113K ﹤0.01% 2169
2020
Q2
$207K Sell
20,098
-20,462
-50% -$211K ﹤0.01% 2291
2020
Q1
$410K Buy
40,560
+14,468
+55% +$146K ﹤0.01% 2152
2019
Q4
$347K Buy
26,092
+4,516
+21% +$60.1K ﹤0.01% 2157
2019
Q3
$185K Buy
+21,576
New +$185K ﹤0.01% 2243